Healthcare -
Biotechnology - NASDAQ - US
$ 4.1
-0.485 %
$ 13.2 M
Market Cap
-0.09
P/E
CING - COST OF REVENUE
Cost of Revenue CING - Cingulate Inc.
583 K
LAST VALUE
-15.09%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR